CSI Market
Sign In | Register

Renalytix Plc (RNLX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access RNLX Annual Cash Flow →
This page allows investors to follow Renalytix Plc's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2024)
3 Months 		(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Operating Activities
Income-4.73
Depreciation & amortization0.01
Amortization of Other Assets0.05
Increase (Decrease) in Deferred Revenue0.00
Impairment of Long-Lived Assets Held-for-use0.00
Provision For Loan Losses Expensed-0.03
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.25
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Realized0.04
Deconsolidation Gain Or Loss Amount-
Debt And Equity Securities Realized Gain Loss-
Reversal Of Kantaro Liability-
Fair Value Adjustment To Vericidx Investment-0.10
Fair Value Adjustment To Convertible Notes-
Fair Value Adjustments To Convertible Debt0.76
Increase Decrease In Accrued Expenses Related Party-1.23
Income taxes0.00
Gain (Loss) on Sales of Loans, Net0.00
Increase (Decrease) in Accounts Receivable0.15
Accounts Payable1.39
Increase (Decrease) in Accrued Liabilities-1.31
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.33
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.04
Discontinued operations0.00
Net Cash flow from Operating Activities-3.84
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale of Short-term Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payment For Long Term Deferred Expense-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Cash Divested from Deconsolidation0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.02
Discontinued operations0.00
Net Cash Flow from Investing Activities0.02
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock14.90
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Gross Proceeds From The Issuance Of Ordinary Shares Net Of Underwriting Fees-
Proceeds From The Issuance Of Ordinary Shares Under Employee Share Purchase Plan-
Payments Of Debt Issuance Costs-
Payment Of Convertible Notes Principal-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow0.04
Discontinued operations0.00
Free Cash Flow-3.84
Total Cash Flow-3.77
4 historic quarters locked

Sign in to unlock the full Renalytix Plc cash flow history.

Sign In Create Free Account

About Renalytix Plc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: November 19, 2024
  • Source: rnlx-20240930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-24-128687

Figures are derived from filed reports and may be restated. Historical data is subject to revision.